非甾体抗炎药或COX-2抑制剂是否增加骨折术后骨不连或延迟愈合率?倾向性评分匹配研究
该研究纳入1998至2018年接受骨折手术的患者,采用倾向性评分1:1匹配比较术后使用与非使用NSAID/COX-2抑制剂者,共匹配3,264例。结果显示NSAID使用者骨不连风险显著低于匹配非使用者(HR 0.69,95%CI 0.48-0.98,p=0.040),但用药超过3周与更高的骨不连/延迟愈合率相关。
要点
- NSAID使用者骨不连风险显著低于匹配非使用者(HR 0.69,95%CI 0.48-0.98)。
- 用药时长≤3周骨不连/延迟愈合率显著更低,>3周显著更高(p=0.001)。
- COX-2抑制剂按用药时长的生存曲线无显著差异(p=0.9)。
核心结论
- NSAIDs/COX-2抑制剂对长骨骨折愈合无短期影响。
- 持续使用超过3周可能与更高的骨不连或延迟愈合率相关。
研究设计与样本
- 回顾性队列研究,纳入1998至2018年接受骨折手术治疗的患者。
- 采用倾向性评分1:1匹配比较术后NSAID/COX-2抑制剂使用者与非使用者,共匹配3,264例患者。
- 主要结局为术后≥6个月诊断骨不连或延迟愈合,次要结局为因骨不连/延迟愈合再手术。
主要发现
- 共8,693例患者纳入分析,208例发生骨不连(178例,2.05%)或延迟愈合(30例,0.35%)。
- 208例中64例(30.8%)因骨不连或延迟愈合接受再手术。
- NSAID使用者骨不连风险显著低于匹配非使用者(HR 0.69,95%CI 0.48-0.98,p=0.040),其他匹配比较的其他结局无显著差异。
- Kaplan-Meier生存分析显示用药时长≤3周和>3周时骨不连/延迟愈合率分别显著更低和更高(p=0.001)。
- COX-2抑制剂按用药时长的生存曲线组间无显著差异(p=0.9)。
关键数值与推荐
- 骨不连/延迟愈合定义为术后≥6个月具有骨不连或延迟愈合诊断代码。
- 证据等级为治疗性III级。
临床怎么用
- 短期使用NSAIDs/COX-2抑制剂未显示增加长骨骨折术后骨不连或延迟愈合风险。
- 应避免持续使用NSAIDs/COX-2抑制剂超过3周,以降低骨不连或延迟愈合风险。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: The effects of nonsteroidal anti-inflammatory drugs (NSAIDs)/cyclooxygenase (COX)-2 inhibitors on postoperative fracture-healing are controversial. Thus, we investigated the association between NSAID/COX-2 inhibitor administration and postoperative nonunion or delayed union of fractures. We aimed to determine the effects of NSAID/COX-2 inhibitor administration on postoperative fracture-healing with use of a common data model. METHODS: Patients who underwent operative treatment of a fracture between 1998 and 2018 were included. To determine the effects of NSAID/COX-2 inhibitor administration on fracture-healing, postoperative NSAID/COX-2 inhibitor users were compared and 1:1 matched to nonusers, with 3,264 patients matched. The effect of each agent on bone-healing was determined on the basis of the primary outcome (nonunion/delayed union), defined as having a diagnosis code for nonunion or delayed union ≥6 months after surgery. The secondary outcome was reoperation for nonunion/delayed union. To examine the effect of NSAIDs/COX-2 inhibitors on bone union according to medication duration, a Kaplan-Meier survival analysis was performed. RESULTS: Of the 8,693 patients who were included in the analysis, 208 had nonunion (178 patients; 2.05%) or delayed union (30 patients; 0.35%). Sixty-four (30.8%) of those 208 patients had a reoperation for nonunion or delayed union. NSAID users showed a significantly lower hazard of nonunion compared with the matched cohort of nonusers (hazard ratio, 0.69 [95% confidence interval, 0.48 to 0.98]; p = 0.040) but did not show a significant difference in the other matched comparison for any other outcomes. Kaplan-Meier survival analysis revealed significantly lower and higher nonunion/delayed union rates when the medication durations were ≤3 and >3 weeks, respectively (p = 0.001). For COX-2 inhibitors, the survival curve according to the medication duration showed no significant difference among the groups (p = 0.9). CONCLUSIONS: Our study demonstrated no short-term impact of NSAIDs/COX-2 inhibitors on long-bone fracture-healing. However, continued use of these medications for a period of >3 weeks may be associated with higher rates of nonunion or delayed union. LEVEL OF EVIDENCE: Therapeutic Level III. See Instructions for Authors for a complete description of levels of evidence.
引用
- Kim H, Kim DH, Kim DM, et al. Do Nonsteroidal Anti-Inflammatory or COX-2 Inhibitor Drugs Increase the Nonunion or Delayed Union Rates After Fracture Surgery?: A Propensity-Score-Matched Study. J Bone Joint Surg Am. 2021. PMID: 34101675. doi:10.2106/JBJS.20.01663
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。